Here is how to handle the most common problems
Initial Metabolic Changes (Days 1-14): While cellular-level metabolic changes begin within hours of the first AOD-9604 administration, noticeable subjective effects typically emerge within the first one to two weeks
Patients who titrate slowly (4-week intervals between dose increases) generate less acute oxidative stress than those who escalate every 2 weeks
Banerji, U
Signs of vitamin B12 deficiency include: Chronic fatigue Shortness of breath Vision problems Numbness and tingling Poor balance Brain fog Memory problems Muscle weakness Anemia These serious health problems can interfere with your quality of life
[33, 34, 35, 36] Mechanism: Typically pre-renal, occurring in the setting of volume depletion from GI losses (nausea, vomiting, diarrhea, reduced oral intake) More frequently seen at higher, obesity-level doses Although generally reno-protective long term, post-marketing data describe acute rises in creatinine following days to weeks of significant GI symptoms Risk factors: Underlying chronic kidney disease Concomitant use of ACE inhibitors, ARBs, diuretics, or SGLT2 inhibitors ED Management: IV fluids Hold GLP-1 and contributing medications Usually reversible with supportive care Future Directions GLP-1 receptor agonists are rapidly evolving beyond their original indications in diabetes and obesity